z-logo
Premium
Intranasal and oral cocaine kinetics
Author(s) -
Wilkinson Paul,
Van Dyke Craig,
Jatlow Peter,
Barash Paul,
Byck Robert
Publication year - 1980
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1980.52
Subject(s) - nasal administration , bioavailability , pharmacokinetics , pharmacology , oral administration , clinical pharmacology , chemistry , medicine
Plasma cocaine levels were determined in 7 subjects after intranasal and oral cocaine. Intranasal doses of 0.19, 0.38, 0.75, 1.5, and 2.0 mg/kg were given as a 10% aqueous solution; 0.38 mg/kg was given as crystalline cocaine HCl. Oral cocaine was administered in doses of 2.0 and 3.0 mg/kg. Intranasal cocaine kinetics were described by a 1‐compartment open model with 2 consecutive first‐order input steps and first‐order elimination. Oral cocaine disposition was described by a 1‐compartment open model with a lag time followed by a single first‐order input phase and first‐order elimination. The mean elimination half‐life (t½) for cocaine by the intranasal route to 7 subjects was 75 ± 5 min (mean±SE). The mean t½ after oral administration to 4 subjects was 48 ± 3 min. The relative bioavailability [as determined by the area under the concentration‐time curve (AUC)] for the 2.0‐mg/kg dose by the intranasal and oral routes was not different. There was a linear increase in AUC with increasing intranasal dose. Clinical Pharmacology and Therapeutics (1980) 27, 386–394; doi: 10.1038/clpt.1980.52

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom